下麵的時壇幹將可以上網了解一下,不要信口開河。

這是以色列的study.

CONCLUSIONS

Among patients 65 years of age or older, the rates of hospitalization and death due to Covid-19 were significantly lower among those who received nirmatrelvir than among those who did not. No evidence of benefit was found in younger adults.

https://www.nejm.org/doi/full/10.1056/NEJMoa2204919

 

所有跟帖: 

這個我已經揭穿過它的騙術了 -blueberry01- 給 blueberry01 發送悄悄話 blueberry01 的博客首頁 (720 bytes) () 01/18/2023 postreply 22:14:53

40-64歲組,服用P藥住院率每十萬人隻降低0.6人,死亡率增加32%。你還推銷? -blueberry01- 給 blueberry01 發送悄悄話 blueberry01 的博客首頁 (574 bytes) () 01/18/2023 postreply 22:24:38

No evidence of benefit was found in younger adults. -goingunder- 給 goingunder 發送悄悄話 (4756 bytes) () 01/18/2023 postreply 22:43:30

對於年輕組,為什麽掩飾no evidence? 明明服P藥死亡率更高 -blueberry01- 給 blueberry01 發送悄悄話 blueberry01 的博客首頁 (66 bytes) () 01/19/2023 postreply 00:44:06

請您先登陸,再發跟帖!